Stein D, Bannet J, Averbuch I, Landa L, Chazan S, Belmaker R H
Psychopharmacology (Berl). 1984;84(4):566-8. doi: 10.1007/BF00431468.
A vasopressin derivative or placebo was administered to 21 chronic schizophrenia patients for 3 weeks in a randomized crossover double-blind design. The patients were divided into those above and below the median on baseline memory measured by the Wechsler memory scale. Vasopressin treatment did not improve memory either in those patients with below median baseline memory or in the group as a whole.
采用随机交叉双盲设计，对21例慢性精神分裂症患者给予一种血管加压素衍生物或安慰剂，为期3周。根据韦氏记忆量表测量的基线记忆情况，将患者分为高于和低于中位数的两组。血管加压素治疗对于基线记忆低于中位数的患者或整个组的记忆均未改善。
